BioSpace News Archive

GE Healthcare and Lantheus Holdings, Inc. (NASDAQ: LNTH), have started a second Phase 3 clinical trial of Flurpiridaz.

Pharm-Olam International provides multiple resources for life science organizations to comply with the new European Union General Data Protection Regulation (GDPR).

Biotech Leader’s Cannabis Division, Evolve Formulas, Prepares to Launch in Canadian Market

The Thermo Scientific TSG Series of refrigerators maintain optimal cold storage conditions with minimal energy consumption and noise output.

The company expects to receive feedback from the China Food and Drug Administration (CFDA) within five business days.

Surmodics, Inc. has announced the launch and immediate availability of MatrixGuard™ Diluent.

Puma Biotechnology, Inc. announced that Health Canada has accepted for review the Company’s New Drug Submission (NDS) for the medicinal product NERLYNX® (neratinib) for the extended adjuvant treatment of adult patients with early stage HER2-overexpressed/amplified breast cancer following adjuvant trastuzumab-based therapy.

Purdue Pharma L.P. announced completion of a Phase 1b dose-ranging study of a novel, potential first-in-class small molecule being investigated for its utility in insomnia associated with alcohol cessation.

With her leadership, the Foundation’s mission of finding a cure for Alpha-1 will be further advanced

RadiaDyne, the designer and manufacturer of the market leading Endorectal Balloon device utilized during radiation therapy for prostate cancer, announced today a pivotal published study utilizing their technology.